Oncology
Novel drug combination shows promise for advanced HER2-negative breast cancer

Novel drug combination shows promise for advanced HER2-negative breast cancer

by Johns Hopkins University School of MedicineClinical efficacy.a–c, Responses as shown by a waterfall plot (a), swimmers plot (b) and spider plot (c). The dashed lines correspond to +20% a
Oncology May 09,2024 4
Novel drug combination shows promise for advanced HER2-negative breast cancer

Novel drug combination shows promise for advanced HER2-negative breast cancer

by Johns Hopkins University School of MedicineClinical efficacy.a–c, Responses as shown by a waterfall plot (a), swimmers plot (b) and spider plot (c). The dashed lines correspond to +20% a
Oncology May 09,2024 4
Clinical trial finds combination hormone therapy delivers superior prostate cancer treatment

Clinical trial finds combination hormone therapy delivers superior prostate cancer treatment

by University of California, San FranciscoCredit: Unsplash/CC0 Public DomainCombining testosterone-blocking drugs in patients with prostate cancer relapse prevents the spread of cancer better tha
Oncology May 09,2024 3
Clinical trial finds combination hormone therapy delivers superior prostate cancer treatment

Clinical trial finds combination hormone therapy delivers superior prostate cancer treatment

by University of California, San FranciscoCredit: Unsplash/CC0 Public DomainCombining testosterone-blocking drugs in patients with prostate cancer relapse prevents the spread of cancer better tha
Oncology May 09,2024 3
Clinical trial shows durvalumab plus ceralasertib boosted immune response in lung cancer patients

Clinical trial shows durvalumab plus ceralasertib boosted immune response in lung cancer patients

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainA specific combination of targeted therapy and immunotherapy may better help patients with non-small cell lung
Oncology May 09,2024 5
Clinical trial shows durvalumab plus ceralasertib boosted immune response in lung cancer patients

Clinical trial shows durvalumab plus ceralasertib boosted immune response in lung cancer patients

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainA specific combination of targeted therapy and immunotherapy may better help patients with non-small cell lung
Oncology May 09,2024 5
Do we need a new standard of care for colorectal cancer?

Do we need a new standard of care for colorectal cancer?

by University of VermontCredit: Pixabay/CC0 Public DomainIn recent years total neoadjuvant treatment (TNT)—a potent new treatment approach for advanced colorectal cancer that confronts tumors wit
Gastroenterology May 09,2024 3
Do we need a new standard of care for colorectal cancer?

Do we need a new standard of care for colorectal cancer?

by University of VermontCredit: Pixabay/CC0 Public DomainIn recent years total neoadjuvant treatment (TNT)—a potent new treatment approach for advanced colorectal cancer that confronts tumors wit
Gastroenterology May 09,2024 3
Eliminating common bacterial infection significantly decreases gastric cancer risk

Eliminating common bacterial infection significantly decreases gastric cancer risk

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainWhile it is well known within the medical community that there is a link between the bacteria Helicobacter
Gastroenterology May 09,2024 5
Eliminating common bacterial infection significantly decreases gastric cancer risk

Eliminating common bacterial infection significantly decreases gastric cancer risk

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainWhile it is well known within the medical community that there is a link between the bacteria Helicobacter
Gastroenterology May 09,2024 5
Chatter between cell populations drives progression of gastrointestinal tumors

Chatter between cell populations drives progression of gastrointestinal tumors

by University of California - San DiegoCredit: CC0 Public DomainGastrointestinal stromal tumors (GISTs) are a subytpe of cancers known as sarcomas. GIST is the most common type of sarcoma with ap
Gastroenterology May 09,2024 8
Chatter between cell populations drives progression of gastrointestinal tumors

Chatter between cell populations drives progression of gastrointestinal tumors

by University of California - San DiegoCredit: CC0 Public DomainGastrointestinal stromal tumors (GISTs) are a subytpe of cancers known as sarcomas. GIST is the most common type of sarcoma with ap
Gastroenterology May 09,2024 8
Elegant antibody nanoparticles override immunological tolerance of tumors

Elegant antibody nanoparticles override immunological tolerance of tumors

by Chinese Academy of SciencesSchematic illustration of the engineered antibody nanoparticle for robust cancer immunotherapy. Credit: WANG DanggeImmune checkpoint blockade (ICB) therapy using the
Oncology May 09,2024 5
Elegant antibody nanoparticles override immunological tolerance of tumors

Elegant antibody nanoparticles override immunological tolerance of tumors

by Chinese Academy of SciencesSchematic illustration of the engineered antibody nanoparticle for robust cancer immunotherapy. Credit: WANG DanggeImmune checkpoint blockade (ICB) therapy using the
Oncology May 09,2024 5
New tools used to identify childhood cancer genes

New tools used to identify childhood cancer genes

by UT Southwestern Medical CenterEmbryonal rhabdomyosarcoma cells. Credit: UT SouthwesternUsing a new computational strategy, researchers at UT Southwestern Medical Center have identified 29 gene
Oncology May 09,2024 5
New tools used to identify childhood cancer genes

New tools used to identify childhood cancer genes

by UT Southwestern Medical CenterEmbryonal rhabdomyosarcoma cells. Credit: UT SouthwesternUsing a new computational strategy, researchers at UT Southwestern Medical Center have identified 29 gene
Oncology May 09,2024 5
H. pylori treatment may reduce gastric cancer incidence, death

H. pylori treatment may reduce gastric cancer incidence, death

(HealthDay)—Helicobacter pyloritreatment, vitamin supplementation, and garlic supplementation are associated with a reduced risk for gastric cancer mortality, according to a study published onli
Oncology May 09,2024 7
H. pylori treatment may reduce gastric cancer incidence, death

H. pylori treatment may reduce gastric cancer incidence, death

(HealthDay)—Helicobacter pyloritreatment, vitamin supplementation, and garlic supplementation are associated with a reduced risk for gastric cancer mortality, according to a study published onli
Oncology May 09,2024 7
Primary pancreatic organoid tumor models for high-throughput phenotypic drug screening

Primary pancreatic organoid tumor models for high-throughput phenotypic drug screening

by SLAS (Society for Laboratory Automation and Screening)A Z-stack image was obtained after staining nuclei with Hoechst using confocal microscopy at 5 micron intervals and then assembled using ImageJ
Oncology May 09,2024 6
Primary pancreatic organoid tumor models for high-throughput phenotypic drug screening

Primary pancreatic organoid tumor models for high-throughput phenotypic drug screening

by SLAS (Society for Laboratory Automation and Screening)A Z-stack image was obtained after staining nuclei with Hoechst using confocal microscopy at 5 micron intervals and then assembled using ImageJ
Oncology May 09,2024 6
More News

Today's News

FOUND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
APP
Medicine.net
Meditionary
PanWriting
PanDraw